Industry

Healthcare & Life Sciences

Pain points

What healthcare & life sciences operators are wrestling with

  • Clinical systems trapped on aging on-premise estates

    EPRs, lab systems and PACS environments make integration, analytics and AI augmentation expensive and slow to deliver safely.

  • Patient data silos undermine care continuity

    Acute, primary, community and social-care records remain fragmented, eroding outcomes and frustrating clinicians.

  • Audit and assurance overhead consumes delivery capacity

    Evidence collection for clinical safety, DSPT and GDPR is largely manual — pulling engineering time away from product.

  • AI ambition outpaces governance maturity

    Boards expect AI-enabled efficiency, but few organisations have the model governance, bias controls or clinical validation maturity to deploy safely.

Regulatory drivers

Frameworks shaping the engineering bar

Named standards we treat as first-class constraints — not after-the-fact compliance theatre.

  • DCB0129 / DCB0160 — Clinical Risk Management
    United Kingdom

    Manufacturer and deploying-organisation obligations for clinical safety case files, hazard logs and clinical safety officer sign-off.

  • NHS DSPT
    United Kingdom

    Annual Data Security and Protection Toolkit evidence demonstrating compliance with the ten data security standards.

  • HIPAA
    United States

    Privacy, Security and Breach Notification rules for protected health information held or processed by covered entities and business associates.

  • EU MDR
    European Union

    Medical device regulation including software as a medical device, with conformity assessment and post-market surveillance obligations.

  • GDPR Article 9
    European Union / United Kingdom

    Special-category data processing conditions for health and genetic data, with heightened consent, DPIA and DPO obligations.

Modernization themes

How we modernise healthcare & life sciences estates

  • 01

    Clinical platform consolidation

    Rationalise EPR, departmental and clinical communication estates onto a smaller, integrated platform with shared identity and audit.

  • 02

    FHIR-led interoperability

    Adopt HL7 FHIR R4 as the integration contract for clinical, operational and population-health workloads — internally and across the wider system.

  • 03

    Trusted research environments

    Federated, governed access to de-identified clinical data supporting research, service planning and AI training without moving raw data.

  • 04

    Safe AI deployment

    Clinical-grade model governance, bias monitoring, human-in-the-loop workflows and evidence-grade evaluation pipelines.

Operational risks

Risks we surface upfront

Transformation carries real exposure. We name it before kickoff so it can be engineered around.

  • Clinical safety regression during migration

    critical

    Workflow changes must preserve clinical pathways and alerting behaviour; clinical safety officers must sign off prior to each rollout phase.

  • Identity and access drift

    high

    NHS smartcard, RBAC role catalogues and contractor lifecycles need automation to avoid access creep and audit findings.

  • Vendor lock around clinical content libraries

    medium

    Proprietary clinical content and SNOMED extensions can entrench incumbents and increase switching cost over time.

Talk to an architect

Have a healthcare & life sciences program in motion?

Walk us through your constraints. We will scope a team, an architecture, and a timeline within one working week.